Immunome, Inc. (IMNM)
NASDAQ: IMNM · Real-Time Price · USD
10.97
-0.11 (-0.99%)
At close: Dec 20, 2024, 4:00 PM
11.67
+0.70 (6.38%)
After-hours: Dec 20, 2024, 4:03 PM EST
Immunome Market Cap
Immunome has a market cap or net worth of $684.71 million as of December 20, 2024. Its market cap has increased by 108.11% in one year.
Market Cap
684.71M
Enterprise Value
447.30M
1-Year Change
108.11%
Ranking
Category
Stock Price
$10.97
Market Cap Chart
Since the IPO on October 2, 2020, Immunome's market cap has increased from $111.39M to $684.71M, an increase of 514.69%. That is a compound annual growth rate of 53.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 684.71M | 49.76% |
| Dec 29, 2023 | 457.21M | 1,605.70% |
| Dec 30, 2022 | 26.80M | -82.91% |
| Dec 31, 2021 | 156.82M | 53.68% |
| Dec 31, 2020 | 102.04M | -8.39% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Avanos Medical | 713.88M |
| Oculis Holding AG | 713.48M |
| Relay Therapeutics | 713.05M |
| Kura Oncology | 697.54M |
| Erasca | 692.68M |
| Evolus | 688.30M |
| Bioventus | 687.67M |
| Keros Therapeutics | 685.39M |